A recent study reveals that dementia could cost the UK almost £91bn annually by 2040, with the number of affected individuals expected to increase significantly. The costs are projected to more than double from the current £42.5bn to £90.6bn, reflecting the rising number of diagnosed cases due to an ageing population.
The Alzheimer’s Society and the British Geriatrics Society are urging the government and NHS to take urgent action to improve early diagnosis of dementia, which is the UK’s largest killer. The lack of timely diagnosis not only impacts the lives of those affected but also imposes dramatic costs on families and the economy.
Research conducted by Carnall Farrar reveals the comprehensive costs of dementia, including healthcare, social care, and economic impacts. Despite the benefits of early diagnosis, only a small fraction of healthcare costs are allocated to this crucial aspect.
Personal stories highlight the devastating effects of delayed diagnosis, emphasizing the urgent need for better healthcare planning and support. With healthcare and social care costs expected to skyrocket, addressing dementia as a priority concern is essential for the wellbeing of individuals and families.